Nurix Therapeutics Cash Flow Statement (2019-2025) | NRIX

Cash Flow Statement Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025
Operating Activities
Net Income -2.43M-13.52M-12.39M7.58M-18.52M-19.90M-24.27M-26.38M-28.84M-37.69M-42.53M-45.40M-45.71M-46.72M-40.73M-24.28M-36.98M-41.96M-41.52M-44.55M-48.96M-58.55M-56.35M-43.46M-86.42M-78.22M
Share-based Compensation 0.17M0.18M0.47M1.11M2.54M2.70M3.94M4.31M4.84M6.07M6.78M6.99M8.30M8.48M8.72M8.45M8.02M7.82M8.85M8.75M8.51M8.72M10.38M9.77M9.09M
Gains from Sales and Divestitures 0.01M0.03M
Gains from Investment Securities 3.46M5.10M5.14M5.59M-12.80M6.52M-0.20M5.27M0.02M0.02M0.03M23.92M0.00M1.30M2.81M5.79M
Non-cash Items 0.76M12.50M141.25M49.70M48.90M54.90M57.90M75.20M68.20M85.90M
Cash from Operations -12.75M40.97M-14.43M-6.14M-20.48M8.05M-31.54M-29.97M-30.91M-42.63M-32.91M-46.31M-37.95M-48.45M-18.47M-41.13M26.69M-41.95M-39.70M-42.18M-48.75M-61.09M-63.16M-57.38M-67.83M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.01M-0.04M-0.08M-0.14M0.74M0.83M0.86M0.85M1.26M1.35M1.43M1.42M1.43M1.44M1.43M1.82M1.93M2.16M3.71M3.49M3.56M2.70M2.20M1.87M
Depreciation & Amortization (CF) 0.60M0.59M0.49M0.50M0.60M0.66M0.64M0.60M0.70M0.77M0.99M1.30M1.50M1.62M1.75M1.90M1.95M1.93M2.04M2.33M2.39M2.55M2.35M2.24M2.03M2.12M
Change in Working Capital
Change in Receivables 2.00M-2.00M
Change in Account Payables 0.04M0.30M1.45M-1.14M0.63M0.90M1.22M-1.39M0.86M-0.10M1.85M-0.76M-0.90M0.40M-2.24M-1.20M4.65M-0.93M-2.54M1.09M7.58M-3.21M-2.68M2.23M3.02M
Change in Accured Expenses 1.61M1.43M-3.32M2.46M1.70M2.17M-2.86M3.53M3.38M-3.32M6.14M1.36M3.30M-6.91M2.26M4.70M3.08M3.59M-6.84M6.04M9.02M6.94M-7.01M6.34M11.04M
Change in Taxes -15.73M-0.01M0.14M-0.84M-2.94M
Other Working Capital Changes -1.86M54.63M-3.18M-4.09M0.81M16.99M2.91M-9.25M3.60M-3.62M-9.43M-9.29M-4.28M-9.18M-5.68M-16.47M50.84M-12.59M4.91M-7.59M-13.28M-9.83M-5.68M-7.89M-13.58M
Investing Activities
Capital Expenditures 0.95M0.36M1.61M1.67M0.91M0.84M2.09M1.86M0.86M3.47M2.79M3.42M2.56M2.28M1.08M2.46M2.58M2.88M1.94M2.35M2.10M3.48M2.67M2.71M5.13M
Change in Acquisitions & Divestments 5.02M10.50M46.20M73.48M64.21M55.02M58.75M62.81M72.77M84.48M40.99M105.62M99.82M76.61M93.20M95.98M110.83M159.50M139.20M142.34M156.19M179.81M
Cash from Investing Activities -4.37M-19.42M-2.34M-108.08M-124.56M-2.39M-57.11M-12.23M-36.52M40.03M-4.76M-63.08M55.01M16.07M43.83M22.77M-14.37M35.51M-131.07M-21.34M-140.82M25.53M71.50M50.48M0.35M
Financing Activities
Cash from Financing Activities 0.08M0.05M119.68M220.42M-1.13M1.36M150.47M1.55M0.50M1.49M0.43M115.41M-0.14M1.48M0.03M1.70M0.01M1.62M237.75M45.77M200.52M1.47M0.01M1.16M236.01M
Additional items
Change in Cash -17.03M21.59M102.92M106.20M-146.17M7.03M61.83M-40.65M-66.93M-1.11M-37.25M6.02M16.92M-30.90M25.39M-16.65M12.32M-4.81M66.98M-17.75M10.95M-34.08M8.34M-5.75M168.52M
Free Cash Flow -13.70M40.61M-16.04M-7.81M-21.39M7.21M-33.63M-31.84M-31.77M-46.10M-35.70M-49.73M-40.52M-50.73M-19.55M-43.59M24.10M-44.84M-41.64M-44.52M-50.86M-64.57M-65.84M-60.10M-72.96M
Net Cash Flow -17.03M21.59M102.92M106.20M-146.17M7.03M61.83M-40.65M-66.93M-1.11M-37.25M6.02M16.92M-30.90M25.39M-16.65M12.32M-4.81M66.98M-17.75M10.95M-34.08M8.34M-5.75M168.52M